Bionano Genomics, Inc. (BNGO)
0.8999
+0.01
(+1.68%)
USD |
NASDAQ |
Nov 20, 10:22
Bionano Genomics Cash from Investing (Quarterly) : 2.411M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.411M |
| June 30, 2026 | 13.68M |
| March 31, 2026 | 5.457M |
| December 31, 2025 | 4.009M |
| September 30, 2025 | -4.669M |
| June 30, 2025 | 1.979M |
| March 31, 2025 | -14.07M |
| December 31, 2024 | 2.997M |
| September 30, 2024 | -5.375M |
| June 30, 2024 | 28.63M |
| March 31, 2024 | 47.59M |
| December 31, 2023 | -55.37M |
| September 30, 2023 | 33.43M |
| June 30, 2023 | 29.58M |
| March 31, 2023 | 16.53M |
| December 31, 2022 | 11.61M |
| September 30, 2022 | 7.953M |
| June 30, 2022 | 31.24M |
| March 31, 2022 | 31.96M |
| December 31, 2021 | -92.51M |
| Date | Value |
|---|---|
| September 30, 2021 | -185.60M |
| June 30, 2021 | 0.074M |
| March 31, 2021 | -0.024M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -2.45M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0227M |
| September 30, 2019 | -0.0087M |
| June 30, 2019 | -0.0296M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0118M |
| September 30, 2018 | -0.1305M |
| June 30, 2018 | -0.1776M |
| March 31, 2018 | -0.0118M |
| December 31, 2017 | |
| September 30, 2017 | -0.2741M |
| June 30, 2017 | -0.3904M |
| March 31, 2017 | -0.0715M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -145.90M |
| Bruker Corp. | -72.70M |
| Danaher Corp. | -300.00M |
| Harvard Bioscience, Inc. | -1.343M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.524M |
| Cash from Financing (Quarterly) | 2.737M |
| Free Cash Flow | -19.08M |
| Free Cash Flow Per Share (Quarterly) | -0.3773 |
| Free Cash Flow to Equity (Quarterly) | -4.363M |
| Free Cash Flow to Firm (Quarterly) | -4.459M |
| Free Cash Flow Yield | -157.0% |